baber/WOPTO huggingface dataset:
Patent NZ-203113-A (NZ)
Title: Blend of lldpe and eva;layered film and shrink bags made therefrom
Inventor: NEWSOME D L
IPC: B32B27/32
Filed: 1983-01-28
Abstract: Molecularly oriented films (10) for use in shrink packaging comprise a blend of 10 to 90% by weight of linear low density polyethylene with ethylene vinyl acetate. The blend can form one layer (16) of a triple layer film laminate, the other layers being a barrier layer (14) for instance comprising an ethylene vinyl alcohol copolymer and a third layer (18) which can be ethylene vinyl acetate or a blend similar or identical to that forming the layer (16). As an alternative, a five layer film can utilize the linear low density polyethylene, for one or more of its layers (116, 120, 122, 118), in the form of a blend as aforesaid or alone. Bags made from the multiple layer films are especially useful for the shrink packaging of meats having large cavities and bony protrusions.
Patent NZ-206619-A (NZ)
Title: Production of spiro-linked tricyclic heterocyclic compounds
Inventor: BEDFORD G R
IPC: C07D487/10
Filed: 1983-12-19
Abstract: The invention concerns a novel press for the racemisation of unwanted enantiomeric forms of 1 min -substituted spiro[imidazolidine-4,3 min -indoline]-2,2 min ,5-triones and 1 min -substituted spiro[pyrrolidine-3,3 min -indoline]-2,2 min ,5-triones which comprises heating an unwanted enantiomeric form (or a mixture containing an excess of one enantiomer over the other) alone or, more conveniently, in the presence of a solvent or diluent at a temperature in the range 80 to 280 DEG C. <CHEM> c
Patent NZ-218293-A (NZ)
Title: Sleeve-type article carrier with locking tabs
Inventor: WILSON JERRY FRANKLIN
IPC: B65D5/462
Filed: 1986-11-14
Abstract: A sleeve-type beverage can carrier having end dust flaps which mechanically interlock by means of locking tabs and cutouts. The flap containing the cutouts overlaps the flap containing the locking tabs so that the cutouts and tabs are aligned. The locking tab is folded back to allow the flap with the cutouts to be moved into place, then is inserted through the cutout and also through the portion of the bottom flap from which the locking tab was struck. This provides a secure mechanical lock. In addition, the blank from which the carrier is formed is designed so that the space between dust flaps is identical in shape to that of the dust flaps. This allows multiple widths of blanks to be cut from the sheet stock without scrap loss.
Patent NZ-224017-A (NZ)
Title: Benzazepine sulphonamides as antiarrhythmic agents
Inventor: CROSS PETER EDWARD
IPC: C07D223/16
Filed: 1988-03-24
Abstract: An antiarrhythmic agent of the formula <CHEM>  or a pharmaceutically acceptable salt thereof;  wherein      R<1> is H, C1-C4 alkyl or C1-C4 alkoxy;      X is O, -NH @- or a direct link;    and R<2> and R<3>, which are the same or different, are each C1-C4 alkyl, with the proviso that when X is -NH @-, R<2>   and R<3> are the same. l
Patent NZ-225024-A (NZ)
Title: Coloured contact lenses simulating natural irises
Inventor: MAGDASSI S
IPC: B29D11/00
Filed: 1988-06-14
Abstract: An opaque contact lens comprises a lens body constructed of polymer and solid latex polymer particles directly bound to at least a portion of a surface of the lens, and is produced by reacting the polymer lens body with a latex emulsion at a temperature of from 35 DEG C to 150 DEG C for from 30 to 90 minutes. The latex emulsion may be applied to the lens body by a transfer printing method in combination with a colouring ink to produce an opaque coloured lens.
Patent NZ-229350-A (NZ)
Title: A process for curing aminoplastic resins using a hexamethylenetetramine salt of a strong acid as a catalyst
Inventor: GARRIGUE ROGER
IPC: C08G12/06
Filed: 1989-05-30
Abstract: -Process for curing aminoplastic resins. -Process for curing aminoplastic resins with the aid of a catalyst consisting of a strong acid salt of hexamethylenetetramine. -Application to the manufacture of particle boards.
Patent NZ-231070-A (NZ)
Title: Method of infusing metal into non-reactive filler material by surrounding metal ingot with filler and heating
Inventor: WHITE DANNY RAY
IPC: B22F3/26
Filed: 1989-10-19
Abstract: The present invention relates to the formation of metal matrix composite bodies by a spontaneous infiltration technique, and novel metal matrix composite bodies produced according to the method. An ingot (4) of matrix metal is surrounded by a permeable mass of filler material (5). An infiltration enhancer and/or an infiltration enhancer precursor and/or an infiltrating atmosphere are also in communication with the filler material (5), at least at some point during the process, which permit the shaped ingot (4) of matrix metal, when made molten, to spontaneously infiltrate the surrounding permeable mass of filler material (5). After the spontaneous infiltration, a metal matrix composite body is produced having therein a cavity which substantially corresponds in shape to the original ingot (4) of matrix metal.
Patent NZ-285565-A (NZ)
Title: Short synthetic peptide elastase inhibitors
Inventor: METZ WILLIAM ARTHUR
IPC: A61P21/00
Filed: 1995-05-05
Abstract: This invention relates to compounds which are inhibitors of elastase, particularly human neutrophil elastase. The inhibitors are short, synthetic peptides in which the P2 moiety is substituted with various nitrogen-containing heterocyclic groups. As inhibitors of human neutrophil elastase, the compounds are useful in the treatment of a patient afflicted with a neutrophil associated inflammatory disease.
Patent NZ-292253-A (NZ)
Title: Ultrasonic spectral contrast imaging
Inventor: ARDITI MARCEL
IPC: A61K49/00
Filed: 1995-09-21
Abstract: Echographic imaging (such as used for medical diagnosis) uses the injection of specific contrast agents in the body, or more generally in the region to be imaged. Different frequency dependent echographic behavior of the ultrasound contrast agents containing microbubbles as compared to echographic behavior of tissue without contrast agents is exploited by providing separated spectral echo responses and then combining them in ways to enhance image contrast. These imaging principles exploit certain physical "signatures" of the contrast agent responses, allowing increased contrast with respect to tissue background. This contrast enhancement is much larger than what is determined from direct echo amplitude monitoring.
Patent NZ-295150-A (NZ)
Title: Contact lenses produced from the polymerisation product of poly-unsaturated carbohydrate derivatives
Inventor: BACHMANN FRANK
IPC: C08F12/00
Filed: 1995-10-16
Abstract: PCT No. PCT/EP95/04052 Sec. 371 Date Apr. 4, 1997 Sec. 102(e) Date Apr. 4, 1997 PCT Filed Oct. 16, 1995 PCT Pub. No. WO96/13511 PCT Pub. Date May 9, 1996The present invention relates to polymerizable derivatives of carbohydrates comprising a carbohydrate radical and more than one radically polymerizable hydrocarbon group which is linked optionally via a spacer to the carbohydrate radical, to homopolymers, copolymers, block copolymers, graft copolymers and polymeric networks thereof, to capsules, fibers, films and coatings having water-binding and biocompatible properties, and to molded articles, for example contact lenses or biomedicinal articles, comprising the mentioned polymers, as well as to processes for the preparation of the mentioned polymers and articles.
Patent NZ-308189-A (NZ)
Title: Filtrating and culturing micro-organisms in a holder comprising an absorbent support maintained in an expansible compressed state against a membrane filter
Inventor: PARTON ADRIAN
IPC: C12M1/26
Filed: 1996-05-23
Abstract: A method and apparatus for filtering microorganisms from a sample and culturing the microorganisms employs a membrane filter (30) in a filter holder (10) in which holder the membrane filter is supported on an absorbent support (26) which is maintained in an expansible compressed state against the membrane filter so that any expansion of the membrane filter when wetted by a sample does not cause bubbling of the membrane filter away from its support entrapping air bubbles and so preventing supply of nutrient from culture medium supplied to the support from reaching the microorganisms on the membrane filter.
Patent NZ-330611-A (NZ)
Title: cleaning drains using a foaming non-caustic composition containing reducing agent
Inventor: STEER FRANK J
IPC: C11D11/00
Filed: 1996-02-23
Abstract: The method of substantially removing a restriction from a drain pipe system comprising: a)	introducing to a drain pipe system having at least one of an organic restriction and an inorganic salt restriction a cleaning composition; b)	activating the cleaning composition by adding a sufficient amount of liquid to the pipe system while maintaining a flow through state in the pipe system; c)	allowing the drain opening active to remain in contact with the restriction for a sufficient time to substantially degrade the restriction and d)	rinsing the drain opening active and restriction from the pipe system wherein the restriction removing method improves the water flow rate of the pipe system by an average of at least 0.7 litres/mins after 16 hours of drain opening active contacting the restriction is claimed. The cleaning composition comprising a foaming gas generation/entrapment carrier and a non caustic drain opening active comprising at least one reducing agent in an amount of 1 to 90% by weight of the cleaning composition.
Patent NZ-332348-A (NZ)
Title: use of triphenylethylene derivatives as antioxidant agents
Inventor: AHOTUPA MARKKU
IPC: A61K31/135
Filed: 1997-05-02
Abstract: The use of a compound of formula I or a pharmaceutically acceptable salt thereof wherein: Hal is halogen; R1 and R2 are independently H or alkyl and R3 is H or OH in the manufacture of a medicament for use in lowering levels of serum lipid peroxides or for use in the prevention or treatment of oxidative tissue damage induced by lipid peroxidation is claimed.
Patent NZ-333344-A (NZ)
Title: Maize promoter sequence for leaf- and stalk-preferred gene expression
Inventor: BARBOUR ENC
IPC: C12N15/82
Filed: 1997-06-11
Abstract: This invention relates generally to mechanisms of gene expression in plants and more specifically to regulation of expression of genes in plants in a "tissue¡preferred" manner.  Regulation of expression is achieved using a transcriptional regulatory unit capable of driving expression of genes within certain tissues of a plant. Said transcriptional regulatory unit is to be utilized for driving expression of genes effective in the control of insect or other pests which threaten plants, ultimately conferring a selective advantage for said plant.
Patent NZ-336040-A (NZ)
Title: Tube coupler, coupler held in sleeve by V-shaped grab ring
Inventor: GUEST JOHN DEREK
IPC: F16L37/12
Filed: 1999-05-31
Abstract: A tube coupling includes a socket 10 with an open end 16.  A cartridge 18 with tapered internal cam surface 19 and tube locking collet 20 is mounted in the open end 16.  The cartridge has an encircling rebate 21 at its outer end 22.  The rebate has a V-shaped recess 23 in the inner corner of the rebate.  A steel grab ring  of V-shaped cross-section is mounted in the rebate.  The ring has a short limb 24 which is trapped in the recess 23.  The outer limb 25 of the grab ring bears against the inside surface of socket 10, to lock the cartridge in place.  The ring has teeth around its periphery to increase its flexibility.
Patent NZ-505183-A (NZ)
Title: KOR agonists that are synthetic tetrapeptides with D-isomer amino acids exhibiting high affinity for the KOR versus the MOR and not penetrating the brain
Inventor: VANDERAH TODD W
IPC: C07K5/107
Filed: 1998-12-22
Abstract: Synthetic opioid peptides, particularly opioid peptides that are highly selective kappa receptor agonists and more particularly agonists that (a) do not penetrate into the brain and (b) exhibit a long-lasting antinociceptive activity in vivo are disclosed.  From these peptides it should be possible to obtain safe analgesics. Peptides that exhibit high selectivity for the kappa opioid receptor (KOR) and long duration of peripheral action without significant entry into the brain are sequences of four D-isomer amino acid residues having a C-terminus which is a mono or di-substituted amide.  Representative compounds, which have an affinity for the KOR at least 1,000 times their affinity for the mu opioid receptor and an ED50 of not greater than about 0.5 mg/kg, includeH-D-Phe-D-Phe-D-Nle-D-Arg-NHEt,H-D-Phe-D-Phe-D-Nle-D-Arg-morpholinyl,H-D-Phe-D-Phe-D-Nle-D-Arg-NH-4-picolyl,H-D-Phe-D-Phe-D-Nle-D-Arg-NHPr,H-D-Phe-D-Phe-D-Nle-D-Arg-thiomorpholinyl,H-D-Phe-D-Phe-D-Nle-D-Arg-NEt2,H-D-Phe-D-Phe-D-Nle-D-Arg-NHMe,H-D-Phe-D-Phe-D-Leu-D-Orn-morpholinyl,H-D-Phe-D-Phe-D-Nle-D-Arg-NHhEt,H-D-Phe-D-Phe-D-Nle-D-Arg-NH-cyclopropyl,H-D-Ala(2Thi)-D-4Cpa-D-Leu-D-Arg-morpholinyl, H-D-Phe-D-Phe-D-Nle-D-Arg-piperidinyl,H-D-Phe-D-Phe-D-Leu-D-Orn-NHEt,H-D-Phe-D-Phe-D-Leu-D-Lys-morpholinyl,andH-D-Phe-D-Phe-D-Nle-D-Arg-piperazinyl.
Patent NZ-508467-A (NZ)
Title: Sustained release heterodisperse hydrogel systems - amorphous drugs
Inventor: BAICHWAL ANAND R
IPC: A61K47/42
Filed: 2000-11-27
Abstract: A method of preparing a bioavailable sustained release oral dosage form by combining (i) a medicament in amorphous form, (ii) a wetting agent and (iii) a sustained release excipient to obtain a mixture. Thereafter drying and milling the obtained mixture to produce a sustained release product and then forming it into orally administrable unit doses. The sustained release excipient comprising a gelling agent, an ionizable gel enhancing agent and an inert diluent, the ratio of inert diluent to gelling agent being from about 1:8 to about 8:1. The ionizable gel enhancing agent increasing the gel strength of a gel formed when the dosage form is exposed to an aqueous solution and the ratio of the medicament to gelling agent being from about 1:3 to about 1:8.
Patent NZ-509998-A (NZ)
Title: Vehicle suspension with linked air bags
Inventor: HAIRE WILLIAM ARTHUR
IPC: B60G17/052
Filed: 1999-07-29
Abstract: A suspension system for use with a vehicle having at least one wheel (12); the suspension system including: at least two airbags (24, 25) arranged as a forward air bag (24) and a rear air bag (25), the forward air bag (24) and the rear air bag (25) being operatively connected to enable high flow-rates of air between them. A vehicle suspension wherein a front differential and a rear differential have extending therebetween a height valve rocker and a link extending from the midpoint of the length of the height valve rocker to a height valve is also disclosed.
Patent NZ-512601-A (NZ)
Title: Method for removing condensables from a natural gas stream, at a wellhead, downstream of the wellhead choke
Inventor: TJEENK WILLINK CORNELIS ANTONI
IPC: F25J3/06
Filed: 1999-12-29
Abstract: A method for removing condensables from a gas stream comprises the steps of: (A) inducing the natural gas stream to flow at supersonic velocity through a conduit of a supersonic inertia separator (1, 358) and thereby causing the fluid to cool to a temperature that is below a temperature/pressure at which the condensables will begin to condense, forming separate droplets and/or particles; (B) separating the droplets and/or particles from the gas and (C) collecting the gas from which the condensables have been removed Characterised in that the supersonic inertia separator is located in the vicinity of the wellhead (352) of the natural gas production well for separation of condensables from the natural gas stream produced through the well (350). A device (1, 358) for removing condensables from the natural gas for use in the method described above comprises: i) an acceleration section wherein gas is accelerated to a supersonic velocity; ii) a collection zone from which a gas stream containing reduced content of condensables is removed Characterised in that the device is located in the vicinity of the wellhead (352) of the natural gas production well for separation of condensables from the natural gas stream produced through the well (350). The device can further comprises a swirl imparting section (15) that imparts a swirling motion to the gas and the collection zone can have a radially outer section of the collecting zone with a radially outer section from which the condensables can be collected.
Patent NZ-520427-A (NZ)
Title: Process for the preparation of acetyl- amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
Inventor: BREIPOHL GERHARD
IPC: C07K5/065
Filed: 2001-01-18
Abstract: A process for the preparation of compounds of the formula I, which comprises converting the compound of the formula II by catalytic hydrogenation and conversion of the cyano group into the amidino group into the compound of the formula III or its salt with the acid HX, followed by reaction with a compound of the formula IV or its salt with the acid HX to give a compound of the formula I, where the anions X are physiologically acceptable anions.
Patent NZ-521937-A (NZ)
Title: Inhibition of cyclooxygenase-2 activity
Inventor: DANNENBERG ANDREW J
IPC: C07D401/04
Filed: 2001-03-30
Abstract: The use of an effective amount of an amide or imide of formula (I) to inhibit activity of cyclooxygenase-2 to reduce prostaglandin biosynthesis in a mammal, where: - R is hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, mopholinomethyl, phenyl or benzyl; and - R' is one of formula (a), (b) or (c). The compound disclosed above may also be thalidomide.
Patent NZ-523194-A (NZ)
Title: Steriods with a 17alpha cyclic ester and their use in the treatment of inflammatory diseases
Inventor: CUENOUD BERNARD
IPC: C07J41/00
Filed: 2001-06-26
Abstract: Disclosed are compounds of formula I wherein R is a monovalent cyclic organic group having 3 to 15 atoms in the ring system. Also described are processes for the preparation of the compounds. The compounds are useful as pharmaceuticals for the treatment of an inflammatory condition.
Patent NZ-523401-A (NZ)
Title: Blade clamping for jigsaw blades of varying thicknesses
Inventor: ACHTERBERG NICHOLAS E
IPC: B23D51/10
Filed: 2002-12-24
Abstract: A saw blade retaining apparatus (20) is provided for selectively retaining one in a series of saw blades (12) having unique thicknesses. The retaining apparatus (20) includes a rocker arm (18) supported by a pair of lateral walls (40,42). The rocker arm (18) includes a contoured contact surface (82) which cooperates with a contoured stop segment (72) extending between the lateral walls (40,42) to securely retain one of a series of saw blades (12) having unique thicknesses.
Patent NZ-524841-A (NZ)
Title: Ferment activator based of lactic acid bacteria and method for preparing a dairy product using same
Inventor: ZINDEL LAURENT
IPC: A23C19/068
Filed: 2001-09-20
Abstract: An activator for a ferment based on lactic acid bacteria, characterised in that it comprises at least: a nitrogenous substance, a buffer system capable of maintaining the activity pH of the lactic acid bacteria and is free of added sugar(s) capable of being metabolised by said lactic acid bacteria. The application also concerns a method for preparing a dairy product characterised in that it consists in using the said activator.
Patent NZ-531661-A (NZ)
Title: Stopper for spoked-wheel rims
Inventor: VARRONE ANTONIO
IPC: B60B21/12
Filed: 2002-09-27
Abstract: A stopper (10) is characterised by a bearing member (12) and a base member. The base member is projecting from a lower surface of the bearing member (12). The base member is proportioned to be received within a spoke access hole (30) of a wheel rim (34).
Patent NZ-532590-A (NZ)
Title: Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
Inventor: BOLD GUIDO
IPC: A61P43/00
Filed: 2002-11-07
Abstract: Disclosed are anthranilic acid amide compounds of formula I, wherein: R1 is H or lower alkyl, R2 is H or lower alkyl, R3 is perfluoro lower alkyl, and X is O or S. The compounds are used in the manufacture of medicaments for use as VEGF receptor tyrosine kinase inhibitors, for the treatment of diseases such as neoplastic disease, retinopathy and age-related macula degeneration.
Patent NZ-540918-A (NZ)
Title: Cationic porphyrin derivatives as antibacterial agents
Inventor: BRUNDISH DEREK
IPC: A61P31/12
Filed: 2003-12-23
Abstract: Disclosed is a cationic porphyrin derivative of formula I wherein: X1-X4 independently represent H, a lipophilic moiety, a phenyl group, alkyl, alkaryl or aralkyl group, or a cationic group of the formula -L-R1-N+(R2)(R3)R4 as described in the specification; z is -CH or N; and Y1-Y4 are absent or independently represent aryl, or optionally substituted alkyl, alkenyl or alkynyl. Compounds of formula I are useful in the treatment of microbial infections.
Patent NZ-543225-A (NZ)
Title: A system and process for grammatical inference
Inventor: STARKIE BRADFORD CRAIG
IPC: G06F17/27
Filed: 2004-04-29
Abstract: A computer implemented grammatical inference system for inferring a grammar from a plurality of example sentences is disclosed. The system selects sentences having a common suffix or prefix component; identifies the other of said suffix or prefix component of each selected sentence; generating rules for generating the example sentences and the other components; reduces the right hand side of each rule on the basis of the right hand sides of the other rules; and generates a grammar on the basis of the reduced rules.
Patent NZ-543609-A (NZ)
Title: Method of preparing a water treatment product
Inventor: AZIZIAN FARID
IPC: B01J20/32
Filed: 2004-05-12
Abstract: Disclosed is a method of preparing a water treatment product, which method comprises the steps of: (i) impregnating a high surface area material with an iron salt solution by spray impregnation; (ii) optionally oxidising the iron salt; and (iii) treating the impregnated material with a base to provide a hydrated ferric oxide coating thereon, wherein the resulting product is recovered without forced drying.
Patent NZ-545884-A (NZ)
Title: Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
Inventor: BARRETT RONALD W
IPC: A61K31/47
Filed: 2004-09-13
Abstract: Disclosed herein is the use of 1-{[(a-isobutanoyloxyethoxy)carbonyl]-aminomethyl}-1-cyclohexane acetic acid in the preparation of a medicament for treating or preventing urinary incontinence in a patient. The medicament is formulated as a sustained release oral dosage form to provide an amount of from 300 to 3600 mg gabapentin equivalents/day, and wherein the sustained release oral dosage form is formulated to release 1-{[(a-isobutanoyloxyethoxy)carbonyl]-aminomethyl}-1-cyclohexane acetic acid gradually over a period of at least about 6 hours after administration of the dosage form, thereby providing a therapeutic concentration of gabapentin in the plasma of the patient.
Patent NZ-547209-A (NZ)
Title: Umbrella clamp for use under outdoor furniture
Inventor: KEENE CHARLES ERNEST
Filed: 2006-05-16
Abstract: An umbrella pole inserted between rubber lined indents 11 is clamped between a clamp block 6 screwed beneath a table surface and an opposing clamp block 7 by tightening the wing nuts 16 on the threaded rods 12 on which block 7 slides. The blocks are biased apart by springs 14 so that one doesn't have to fiddle about beneath the table to open the blocks so that the pole can be inserted between them.
Patent NZ-547795-A (NZ)
Title: 3-Cyano-quinoline derivatives with antiproliferative activity
Inventor: FREYNE EDDY JEAN EDGARD
IPC: C07D498/08
Filed: 2004-12-15
Abstract: Disclosed is a compound of formula (I), or an N-oxide, pharmaceutically acceptable addition salt or stereoisomer thereof, where Z is O, NH, or S, and the other substituents are as disclosed in the specification. Also disclosed is a process for preparing the compound, and its use in treating cell proliferative disorders such as atherosclerosis, restenosis, and cancer.